New Drug Reverses Alzheimer's Disease Within Days In Mouse Models Recent research has implicated dysregulation of metal ions in the brain, particularly copper and zinc, in the pathogenesis of AD and the damaging accumulation of amyloid beta (A) protein that is characteristic of this devastating disease.
Ionophore reverses Alzheimer's within days in mouse models Recent research has implicated dysregulation of metal ions in the brain, particularly copper and zinc, in the pathogenesis of AD and the damaging accumulation of amyloid beta (A?) protein that is characteristic of this devastating disease.
Chronic Myelogenous Leukemia in the Age of Targeted Therapy: Recommendations From an Expert Panel Credits Available Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)" for physicians This program is based on a discussion by an expert panel convened at the American Society of Hematology Meeting, December 7, 2007, in Atlanta, Georgia...
Sequencing of ancient corn landraces to Maize was first domesticated in the highlands of Mexico about 10,000 years ago and is now one of the most important crop plants in the world.It is a member of the grass family, which also hosts the world's other major crops including rice...
Ancient Mexican Maize Varieties: Sequencing Of Ancient Corn Landraces To Ensure Genetic Diversity And Resource Maize was first domesticated in the highlands of Mexico about 10,000 years ago and is now one of the most important crop plants in the world.It is a member of the grass family, which also hosts the world's other major crops including rice...
Oil Rises, Dow Falls - Fast Money Recap (6/26/08) L / ANR / C / COF / COP / CSCO / FCX / GM / GS / HAL / IBM / JPM / LLL / MER / MRK / MS / NUE / ORCL / QID / RIMM / SMH / SU / TXN / USO / UUP Font Size: Print Wall Street Storm: Citigroup (C), Morgan Stanley (MS), GM (GM), Merrill Lynch ...
Ancient Mexican maize varieties EUREKALERT Contact: Dr.Jean-Philippe Vielle-Calzada 462-623-9634 Sequencing of ancient corn landraces to ensure genetic diversity and resources Maize was first domesticated in the highlands of Mexico about 10,000 years ago and is now one...
60 hands to celebrate 60 years The Royal College of Nursing has made its mark in the history of Nottinghams two main hospitals by taking part in a novel 60th anniversary celebration of the NHS.Sixty people aged between one and 60 were invited by Nottingham University...
Frontline Dasatinib Demonstrates Rapid Response in Patients With Previously Untreated Chronic-Phase Chronic My Recent news - Chronic Myeloid Leukemia (CML) Dasatinib Benefits Children and Adolescents With Relapsed or Refractory Leukaemia: Presented at EHA- (DGDispatch) High-Dose Imatinib Offers No Additional Benefit to Standard Dose as First-Line...
Cort Johnson Interviews ME/CFS Victor Martha Kilcoyne _ Cort Johnson Interviews ME/CFS Victor Martha Kilcoyne.
New data shows Glivec 800 mg dose more effective than 400 mg dose in initial treatment New data from a large, international clinical trial find that patients with newly diagnosed chronic myeloid leukaemia who received Glivec (imatinib) at 800 mg/day as their initial treatment achieved clinical milestones significantly faster...
High-Dose vs Standard-Dose Imatinib in Treatment-Naive Patients With Newly Diagnosed CML: Presented at EHA my personal edition> chronic myeloid leukemia (cml) > news E-Mail this DGDispatch to a colleague DGDispatch COPENHAGEN, Denmark -- June 15, 2008 -- High-dose versus standard-dose imatinib induces rapid responses and a trend...
Bosutinib Induces Response in Patients With CML Resistant or Intolerant to Imatinib, Other TKIs: Presented at my personal edition> chronic myeloid leukemia (cml) > news E-Mail this DGDispatch to a colleague DGDispatch COPENHAGEN, Denmark -- June 15, 2008 -- Bosutinib has demonstrated efficacy and a good tolerability profile in patients...
Exelixis Presents Clinical Data Supporting the Safety and Initial Clinical Activity of XL228 in Chronic and Ac Compound Inhibits Mutant Forms of BCR-ABL That Cause Resistance to Current CML and ALL Therapies COPENHAGEN, Denmark, June 13, 2008 /PRNewswire-FirstCall/ -- Exelixis, Inc.today reported preliminary phase 1 data from an ongoing trial of...
Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chr - Efficacy and safety profile in large randomized Phase III study consistent with landmark IRIS trial, which established Gleevec as standard of care EAST HANOVER, N.J., June 13, 2008 /PRNewswire/ -- New data from a large, international...
Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patient - Tasigna (nilotinib) Effective in 77% of Patients Resistant or Intolerant to Prior Treatment in the Chronic (Early) Phase of Chronic Myeloid Leukaemia (CML)(1) - Highly Targeted Nature of Tasigna Tackles the Root Cause of CML Whilst...
